Tribal Bio TRIBAL BIO

THE PLATFORM

Our product offerings.

Three modules covering the early life of a molecule, finding and scoring assets, clearing the regulatory path, and running the pre-clinical package. Each is a synthetic team you open in the console.

A glass jar of white tablets labelled Tribal Bio · new medicine · small molecule inhibitor.
TRIBAL · BIO · NEW MEDICINE · SMALL MOLECULE INHIBITOR

MODULE 01

Asset Discovery & Evaluation

Point the platform at a target or an indication and it screens the landscape, public assets, patents and clinical precedent, then scores every candidate on developability, freedom-to-operate and speed to clinic.

  • Target & indication landscaping across PubMed, patents and trials
  • Developability and FTO scoring on every candidate
  • Ranked shortlist with the rationale behind each call

Agents run the industry-standard discovery stack, scientific literature, patent databases and trial registries, and are trained on Tribal's proprietary corpus of real development programs.

tribalbio.com/console · discovery
Asset evaluation AI · ranked
1,240Screened
38Shortlist
6Advanced
IL-17A small moleculeFTO clear · dermatology
9.2
TYK2 allostericFTO partial · immunology
8.1
JAK1 selectiveFTO clear · derm/resp
7.4

MODULE 02

Regulatory Affairs

A regulatory team that maps your route to the agency, drafts the pre-IND and IND modules, and keeps every claim tied to precedent across the FDA, EMA and MHRA.

  • 505(b)(1)/(2) strategy and agency precedent mapping
  • Pre-IND and IND module authoring
  • Correspondence and meeting prep, tracked end to end

Agents work the same industry-standard regulatory publishing tools your team uses, trained on Tribal's proprietary corpus of real IND packages and FDA / EMA correspondence.

tribalbio.com/console · regulatory
Regulatory pathway 505(b)(1)
4 / 5IND modules
17Precedents
Q3Pre-IND
✓Pre-IND briefing document
✓Module 1 · administrative
✓Module 2.4 · nonclinical overview
Module 3.2 · CMC drafting
Agency meeting request

MODULE 03

Pre-clinical

From lead series to IND-enabling package: tox strategy, species selection, PK/ADME and study design, with GLP oversight built in from the first study.

  • Tox strategy, species selection and study design
  • PK/ADME, safety pharmacology and bridging rationale
  • GLP-ready study reports and gap analysis

Agents drive industry-standard computational tools, PK/PD modelling, tox prediction and structure analysis, running them on Tribal's own servers, and are trained on a proprietary corpus of real pre-clinical study data.

tribalbio.com/console · pre-clinical
Pre-clinical package GLP
✓28-day repeat-dose tox · rat
✓PK / ADME profile
hERG & safety pharmacology running

THE FLYWHEEL

New tools, built from the data each program leaves behind.

Every module captures proprietary data as your team works, the assets it scores, the regulatory precedent it maps, the pre-clinical studies it runs. We feed that data straight back into new tools and sharper agents, so each biotech that runs on Tribal after you starts further ahead. The whole platform compounds.

Open the console and meet your team.

Sign in → How it works